BIOMAT Database Logo BIOMAT Database Logo

Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients. 2006

Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Fundación de Ayuda al Inmunodeficiente, Buenos Aires, Argentina.

Here we present a survey including 52 drug-naive recently HIV-1-infected subjects from Buenos Aires City and province (79%) and 3 other regions in Argentina (21%). Recent infections were established from previous negative serology (32/52), indeterminate Western blot (12/52), or acute retroviral syndrome after high-risk HIV exposure (8/52) within 9 months before genotyping (median time, 4.2 months). Genotyping was performed from plasma by sequencing both protease and reverse transcriptase. Phylogenetic analysis combined with bootscanning resulted in 21 subtype B sequences and 31 B/F recombinants (RecBF). On protease, minor resistance-related mutations were found in both subtype B and RecBF with low frequencies. The substitution L89M, recently suggested as a resistance-related mutation in some subtype F viruses, was observed in 1 RecBF. On reverse transcriptase, major resistance-related mutations were found in 4 of 52 (7.7%) patients from different health centers: M41L (subtype B) and K103N+/-P225H (1 RecBF and 2 subtype B). The greater than 5% resistance threshold found indicates a need for sentinel resistance surveillances calling for an update in the current resistance testing guidelines in Argentina.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001118 Argentina Country located in southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors.
January 1996, Biochemistry,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Reverse transcriptase inhibitors drug resistance mutations in drug-naive HIV type 1 positive Kenyans.
January 2011, East African medical journal,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients.
July 1999, AIDS (London, England),
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.
December 1999, Journal of medical virology,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.
February 2004, AIDS research and human retroviruses,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Differential impact of resistance-associated mutations to protease inhibitors and nonnucleoside reverse transcriptase inhibitors on HIV-1 replication capacity.
August 2013, AIDS research and human retroviruses,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.
January 1992, Journal of enzyme inhibition,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.
October 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations.
March 2006, AIDS research and human retroviruses,
Alejandro Petroni, and Gabriel Deluchi, and Daniel Pryluka, and Flavio Rotryng, and Raul Bortolozzi, and Gustavo Lopardo, and María Belén Bouzas, and Inés Zapiola, and Daniela Garone, and Claudia Rodríguez, and Eduardo Chiocconi, and María Esther Lázaro, and Fernando Murano, and Aldo Maranzana, and Stella Maris Oliva, and Marta Aparicio, and Marcelo Beltrán, and Jorge A Benetucci
Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug.
February 1992, AIDS research and human retroviruses,
Copied contents to your clipboard!